CRUCELL SWITZERLAND AG has a total of 16 patent applications. Its first patent ever was published in 1996. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are CHILDREN S HOSPITAL OF EASTERN ONTARIO RES INST INC, AVEXIS INC and NABEL GARY J.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 4 | |
#3 | Australia | 2 | |
#4 | China | 1 | |
#5 | EAPO (Eurasian Patent Organization) | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Lazar Hedvika | 10 |
#2 | Herzog Christian | 9 |
#3 | Billeter Martin A | 3 |
#4 | Spielhofer Pius | 3 |
#5 | Kaelin Karin | 3 |
#6 | Schneider Henriette | 3 |
#7 | Radecke Frank | 3 |
#8 | Fichera Epifanio | 2 |
#9 | Lempereur Laurence | 2 |
#10 | Assero Giovanna | 2 |
Publication | Filing date | Title |
---|---|---|
CN101754770A | Intradermal influenza vaccine | |
EP1802746A2 | Virosome particles comprising antigens from influenza virus and hepatitis b virus |